Bank of America
BMY.RT

Bank of America’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bank of America’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,577,732
Closed -$1.09M – 8078
2020
Q4 		$1.09M Sell
1,577,732
-1,050,022
-40% -$2.24M ﹤0.01% 4425
2020
Q3 		$5.91M Sell
2,627,754
-160,200
-6% -$457K ﹤0.01% 2758
2020
Q2 		$9.98M Sell
2,787,954
-256,134
-8% -$924K ﹤0.01% 2215
2020
Q1 		$11.6M Sell
3,044,088
-166,831
-5% -$550K ﹤0.01% 1942
2019
Q4 		$9.66M Buy
+3,210,919
New +$8.35M ﹤0.01% 2585

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Bank of America's BMY.RT Position: Q1 2021 in Review

Bank of America sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 1,577,732 shares — an estimated $1.09M sold.

Bank of America first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $11.6M in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Bank of America reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Bank of America sold 1,577,732 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $1.09M.
  • Bank of America first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Bank of America's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $11.6M in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Bank of America's 13F filing for Q1 2021, filed 14 May 2021.